Availability of drugs and resistance testing for bedaquiline, pretomanid, linezolid, and moxifloxacin (BPaL(M)) regimen for rifampicin-resistant tuberculosis in Europe: author's response.

Subjects

Subjects :

Humans
Europe
Linezolid pharmacology
Linezolid therapeutic use
Microbial Sensitivity Tests
Fluoroquinolones pharmacology
Fluoroquinolones therapeutic use
Rifampin pharmacology
Rifampin therapeutic use
Moxifloxacin therapeutic use
Moxifloxacin pharmacology
Mycobacterium tuberculosis drug effects
Nitroimidazoles therapeutic use
Nitroimidazoles pharmacology
Oxazoles
Antitubercular Agents pharmacology
Antitubercular Agents therapeutic use
Tuberculosis, Multidrug-Resistant drug therapy
Tuberculosis, Multidrug-Resistant microbiology
Diarylquinolines therapeutic use
Diarylquinolines pharmacology

Details

Language :

English

ISSN :

1469-0691

Volume :

30

Issue :

9

Database :

MEDLINE

Journal :

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases

Publication Type :

Editorial & Opinion

Accession number :

38901496

Full Text :

https://doi.org/10.1016/j.cmi.2024.06.009